Chronic joint pain, tendon injuries, and ligament issues often leave patients searching for long-term relief. Two commonly discussed treatment options are prolotherapy and cortisone injections. While both aim to reduce pain and improve function, they differ significantly in their mechanisms, duration of effects, and long-term outcomes. This post explores how each treatment works and which offers longer-lasting results.
What Is Prolotherapy?
Prolotherapy, or “proliferation therapy,” is a regenerative injection treatment that stimulates the body’s natural healing processes. It involves injecting an irritant solution—typically dextrose—into damaged ligaments, tendons, or joints. This controlled irritation is thought to provoke an inflammatory response that promotes tissue repair and strengthening over time (Hauser et al., 2016).
Mechanism of Action
Prolotherapy aims to regenerate and strengthen connective tissues by stimulating the production of collagen and extracellular matrix components (Rabago et al., 2010). This process can take several weeks to months, with patients usually receiving multiple treatments spaced apart.
What Are Cortisone Injections?
Cortisone injections involve the injection of corticosteroids directly into inflamed or painful areas. They are primarily used for quick, short-term pain relief in conditions like arthritis, bursitis, and tendinitis (Habib, 2009).
Mechanism of Action
Corticosteroids reduce inflammation by suppressing the immune system’s inflammatory pathways. While this can provide rapid symptom relief, it does not promote healing or tissue regeneration.
Duration of Relief: Prolotherapy vs Cortisone
Cortisone Injections
Cortisone injections often provide pain relief within days and can last several weeks to a few months (Habib, 2009). However, the relief is typically temporary, and repeated injections can weaken tendons, ligaments, and cartilage over time (Coombes et al., 2010).
Prolotherapy
Studies suggest that prolotherapy provides more gradual but longer-lasting benefits. For example, a randomized controlled trial by Rabago et al. (2013) found that prolotherapy significantly improved knee osteoarthritis symptoms, with benefits persisting for at least one year post-treatment. Similarly, another study showed sustained pain reduction and improved function in patients with tendinopathies up to 15 months post-treatment (Hauser et al., 2016).
Head-to-Head Comparisons
Direct comparative studies between prolotherapy and cortisone injections are limited, but available evidence suggests:
-
Short-Term Relief: Cortisone offers faster pain reduction, typically within days.
-
Long-Term Benefits: Prolotherapy may yield more durable improvements by addressing the underlying tissue weakness rather than merely masking inflammation.
Risks and Considerations
-
Cortisone Injections: Risk of tissue degeneration, tendon rupture, and joint cartilage damage with repeated use (Coombes et al., 2010).
-
Prolotherapy: Generally considered safe but may cause temporary pain flare-ups post-injection. Success often requires multiple sessions.
Conclusion
If you’re seeking rapid, short-term relief, cortisone injections may be appropriate. However, for longer-lasting improvement and tissue regeneration, prolotherapy shows more promise based on current evidence.
Always consult with a healthcare provider to determine the best treatment strategy tailored to your specific condition and health profile.
References
-
Coombes, B. K., Bisset, L., & Vicenzino, B. (2010). Efficacy and safety of corticosteroid injections and other injections for management of tendinopathy: a systematic review of randomized controlled trials. The Lancet, 376(9754), 1751-1767.
-
Hauser, R. A., Lackner, J. B., Steilen-Matias, D., & Harris, D. K. (2016). A systematic review of dextrose prolotherapy for chronic musculoskeletal pain. Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders, 9, 139-159.
-
Habib, G. S. (2009). Systemic effects of intra-articular corticosteroids. Clinical Rheumatology, 28(7), 749-756.
-
Rabago, D., Zgierska, A., Fortney, L., et al. (2010). Hypertonic dextrose injection (prolotherapy) for knee osteoarthritis: A randomized controlled trial. Annals of Family Medicine, 11(3), 229-237.
-
Rabago, D., Patterson, J. J., Mundt, M., & Kijowski, R. (2013). Dextrose prolotherapy for knee osteoarthritis: a randomized controlled trial. Annals of Family Medicine, 11(3), 229-237.